Mission
The Organization was established to further the broad interests of antibodyengineering and antibody therapeutics and to safeguard the public interest byincreasing discussion and activities to create the safe, thorough testing of antibody therapeutics. The society encompasses this increasingly diverse field by supporting the superstructure for the engineering of recombinant antibodies, single scaffold binders, etc. through basic and applied research by those in academics and the private sector. The Society also seeks to provide a forum and voice for thethousands of people now working on all facets of this global field.